Product

HM201

Aliases

Pegylated human adrenomedullin

1 clinical trial

2 indications

Indication

ulcerative colitis

Indication

Crohn's disease

Clinical trial

A First-in-human, Double-blind, Placebo-controlled, Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Intravenous Doses of HM201 (Pegylated Human Adrenomedullin) in Healthy Subjects (Adults)

Status: Completed, Estimated PCD: 2022-12-19